BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23969317)

  • 1. Integrating virtual and biochemical screening for protein tyrosine phosphatase inhibitor discovery.
    Martin KR; Narang P; Medina-Franco JL; Meurice N; MacKeigan JP
    Methods; 2014 Jan; 65(2):219-28. PubMed ID: 23969317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
    Zhang ZY
    Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of small molecule inhibitors of PTPĪƒ through an integrative virtual and biochemical approach.
    Martin KR; Narang P; Xu Y; Kauffman AL; Petit J; Xu HE; Meurice N; MacKeigan JP
    PLoS One; 2012; 7(11):e50217. PubMed ID: 23185579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Paradigm for KIM-PTP Drug Discovery: Identification of Allosteric Sites with Potential for Selective Inhibition Using Virtual Screening and LEI Analysis.
    Adams J; Thornton BP; Tabernero L
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Allosteric Inhibitors of Protein Tyrosine Phosphatases Through High-Throughput Screening.
    Hayashi T; Hatakeyama M
    Methods Mol Biol; 2023; 2691():235-245. PubMed ID: 37355550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions.
    Reddy RH; Kim H; Cha S; Lee B; Kim YJ
    J Microbiol Biotechnol; 2017 May; 27(5):878-895. PubMed ID: 28238001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
    Krabill AD; Zhang ZY
    Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Tyrosine Phosphatases: Time to End the Stigma.
    Stanford SM; Bottini N
    Trends Pharmacol Sci; 2017 Jun; 38(6):524-540. PubMed ID: 28412041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
    Burke TR; Zhang ZY
    Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule tools for functional interrogation of protein tyrosine phosphatases.
    He R; Zeng LF; He Y; Zhang S; Zhang ZY
    FEBS J; 2013 Jan; 280(2):731-50. PubMed ID: 22816879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
    Bishop AC; Zhang XY; Lone AM
    Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
    Shen K; Qi L; Stiff L
    Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic substrate enhancement for the identification of specific, second-site-binding fragments targeting a set of protein tyrosine phosphatases.
    Schmidt MF; Groves MR; Rademann J
    Chembiochem; 2011 Nov; 12(17):2640-6. PubMed ID: 22052725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific inhibitors of protein tyrosine phosphatases.
    Hoffman HE; Blair ER; Johndrow JE; Bishop AC
    J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of the Yersinia protein tyrosine phosphatase through high throughput and virtual screening approaches.
    Hu X; Vujanac M; Southall N; Stebbins CE
    Bioorg Med Chem Lett; 2013 Feb; 23(4):1056-62. PubMed ID: 23294700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combinatorial strategy for the acquisition of potent and specific protein tyrosine phosphatase inhibitors.
    Zhang S; Chen L; Lawrence DS; Zhang ZY
    Methods Mol Biol; 2012; 928():53-65. PubMed ID: 22956133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional studies of protein tyrosine phosphatases with chemical approaches.
    Zhang ZY
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidentate inhibitors of protein tyrosine phosphatases.
    Low JL; Chai CL; Yao SQ
    Antioxid Redox Signal; 2014 May; 20(14):2225-50. PubMed ID: 24206395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting protein tyrosine phosphatases for anticancer drug discovery.
    Scott LM; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
    Curr Pharm Des; 2010 Jun; 16(16):1843-62. PubMed ID: 20337577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery and protein tyrosine phosphatases.
    Blaskovich MA
    Curr Med Chem; 2009; 16(17):2095-176. PubMed ID: 19519384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.